^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Tepezza (teprotumumab-trbw)

i
Associations
Trials
Company:
Amgen, Genmab, Roche
Drug class:
IGF-1R inhibitor
Associations
Trials